alt Hacker NewsThis appears to be a potentially huge win for health. The market has Moderna up 153% at time of writing, which is some sort of validation I suppose.
Related stories:
https://www.fiercebiotech.com/biotech/merck-and-modernas-per...
https://www.reuters.com/legal/litigation/merck-moderna-say-m...
https://www.wsj.com/health/pharma/moderna-merck-vaccine-succ...
Replies
not really a huge win. It's going to cost taxpayers significancy and may not improve survival much or total life expectancy . The stock is way overextended, assuming it even works well enough to be a commercial success. History has shown this is seldom the case. I would short it if wasn't so expensive and risky to do so. They would not even specify how much it improved the 5 year survival rate.
oh nice. If it goes up another 100% I may not lose money on this stock anymore.